MedPath

SIGNOS INC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Using Signos mHealth Platform in Adults for Weight Management

Not Applicable
Active, not recruiting
Conditions
Metabolic Syndrome
Weight Loss
Overweight and Obesity
Interventions
Device: Signos System
Other: Standard Lifestyle Education
First Posted Date
2024-01-19
Last Posted Date
2024-10-08
Lead Sponsor
Signos Inc
Target Recruit Count
380
Registration Number
NCT06214221
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Helios Clinical Research, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Seattle Clinical Research, Seattle, Washington, United States

๐Ÿ‡บ๐Ÿ‡ธ

Helios Clinical Research (Phoenix), Phoenix, Arizona, United States

and more 2 locations

Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)

Not Applicable
Recruiting
Conditions
Central Obesity
Metabolic Glucose Disorders
Weight Loss
Metabolic Syndrome
Glucose Intolerance
Diabetes Mellitus, Type 2
Insulin Resistance
Interventions
Device: Continuous Glucose Monitor Device
First Posted Date
2023-05-25
Last Posted Date
2024-01-12
Lead Sponsor
Signos Inc
Target Recruit Count
20000
Registration Number
NCT05874635
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Signos, Palo Alto, California, United States

Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform

Not Applicable
Recruiting
Conditions
Pre-diabetes
Metabolic Syndrome
Glucose Intolerance
Weight Loss
Central Obesity
Metabolic Glucose Disorders
Interventions
Device: Continuous Glucose Monitor Device
First Posted Date
2021-11-16
Last Posted Date
2024-06-13
Lead Sponsor
Signos Inc
Target Recruit Count
100000
Registration Number
NCT05121844
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Signos, Palo Alto, California, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath